Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-3-methyl-1-(pyridin-2-yl)butan-1-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

144852-40-4

Post Buying Request

144852-40-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

144852-40-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 144852-40-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,8,5 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 144852-40:
(8*1)+(7*4)+(6*4)+(5*8)+(4*5)+(3*2)+(2*4)+(1*0)=134
134 % 10 = 4
So 144852-40-4 is a valid CAS Registry Number.

144852-40-4Downstream Products

144852-40-4Relevant articles and documents

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

-

Paragraph 0262, (2014/02/15)

The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

-

Page/Page column 29, (2014/05/07)

The invention is a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).

INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

-

Page/Page column 107, (2013/04/25)

The present teaching provide indazole compounds represented by Structural Formulae (I) or (I') or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as T

Chiral ligands containing heteroatoms; 9. General procedures for the synthesis of optically active 1-(2-pyridyl)alkylamines from α-amino acids

Falorni,Chelucci,Conti,Giacomelli

, p. 972 - 976 (2007/10/02)

General syntheses of 1-(2-pyridyl)alkylamines and N-methyl or N,N-dimethyl-1-(2-pyridyl)alkylamines from optically active α-amino acids are described. The presented procedures are based on catalyzed co-cyclotrimerization of the suitable nitriles with acet

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 144852-40-4